🇺🇸 TAU in United States
35 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 35
Most-reported reactions
- Headache — 5 reports (14.29%)
- Papilloedema — 5 reports (14.29%)
- Arthralgia — 4 reports (11.43%)
- Paraesthesia — 4 reports (11.43%)
- Abdominal Pain Upper — 3 reports (8.57%)
- Benign Intracranial Hypertension — 3 reports (8.57%)
- Diarrhoea — 3 reports (8.57%)
- Dyspnoea — 3 reports (8.57%)
- Fatigue — 3 reports (8.57%)
- Back Pain — 2 reports (5.71%)
Other Neurology approved in United States
Frequently asked questions
Is TAU approved in United States?
TAU does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for TAU in United States?
Montefiore Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.